Narrative review / 2000
Large doses of MSG without food may elicit more symptoms than placebo in self-reported reactors, but responses were infrequent, inconsistent, and not reproducible.
This review examined alleged reactions to monosodium glutamate (MSG) and reported on a multicenter double-blind placebo-controlled challenge study in 130 subjects who report symptoms from ingesting MSG. The findings suggest that large doses of MSG given without food may elicit more symptoms than placebo in individuals who believe they react adversely to MSG. However, the frequency of responses was low, and the reported responses were inconsistent and not reproducible. In addition, these responses were not observed when MSG was given with food.
- Study type
- Review including a multicenter double-blind placebo-controlled challenge study
- Who was studied
- 130 subjects who report symptoms from ingesting monosodium glutamate (MSG)
- What was measured
- Symptom response to MSG ingestion
THE PAPER
Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study.
Geha RS, Beiser A, Ren C, Patterson R, Greenberger PA, Grammer LC, Ditto AM, Harris KE, Shaughnessy MA, Yarnold PR, Corren J, Saxon A. J Nutr, 2000.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.